Stockholders' Equity - Narrative (Details)					3 Months Ended		170 Months Ended
	Mar. 27, 2024 USD ($) $ / shares shares	Sep. 05, 2023 USD ($)	Sep. 04, 2023 USD ($)	Feb. 13, 2023 USD ($) $ / shares shares	Mar. 31, 2024 USD ($) period $ / shares shares	Mar. 31, 2023 USD ($) $ / shares shares	Mar. 31, 2024 USD ($) period $ / shares shares	Dec. 31, 2023 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award
Common stock, shares authorized (in shares) | shares					400,000,000		400,000,000	400,000,000
Common stock, par value (in dollars per share) | $ / shares					$ 0.01		$ 0.01	$ 0.01
Preferred stock, authorized (in shares) | shares					100,000,000		100,000,000
Preferred stock, par value (in dollars per share) | $ / shares					$ 0.01		$ 0.01
Issuance of common stock (in shares) | shares						350,000
Weighted average offering price (in dollars per share) | $ / shares					$ 64.00	$ 63.30
Total compensation to the applicable sales agents					$ 2,200,000
Underwriting discount and offering costs					$ 3,226,000	$ 943,000
Shares repurchase program, authorized repurchase amount (in shares) | shares					3,000,000		3,000,000
Withdraw from deferred compensation plan (in shares) | shares					0	0
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award
Grant date fair value per share of restricted stock awards (in dollars per share) | $ / shares					$ 60.93
Fair value of the restricted stock granted					$ 3,300,000
Unrecognized compensation costs related to restricted stock issuances					$ 15,400,000		$ 15,400,000
Remaining weighted average period					3 years
Expense					$ 1,400,000	$ 1,400,000
Minimum | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award
Grant date fair value per share of restricted stock awards (in dollars per share) | $ / shares							$ 14.20
Vesting period for the restricted stock					3 years
Maximum | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award
Grant date fair value per share of restricted stock awards (in dollars per share) | $ / shares							$ 78.33
Vesting period for the restricted stock					5 years
Common Shares Held in Deferred Compensation Plan
Share-based Compensation Arrangement by Share-based Payment Award
Deposits to deferred compensation plan (in shares) | shares					0	94,794
2019 Plan
Share-based Compensation Arrangement by Share-based Payment Award
Common stock, shares authorized (in shares) | shares					1,898,961		1,898,961
Remaining balance of shares available (in shares) | shares					455,910		455,910
Long Term Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares issued (in shares) | shares					0
Number of measurement periods | period					3		3
$500 Million ATM Program
Share-based Compensation Arrangement by Share-based Payment Award
Common stock aggregate offering price					$ 500,000,000
Common stock aggregate offering price, remaining					155,200,000
Net proceeds form offerings					$ 148,400,000
Number of shares issued (in shares) | shares					2,353,278
$300 Million ATM Program
Share-based Compensation Arrangement by Share-based Payment Award
Common stock aggregate offering price		$ 300,000,000	$ 300,000,000
Net proceeds form offerings						$ 21,800,000
Total compensation to the applicable sales agents						$ 300,000
IPO | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award
Net proceeds form offerings	$ 387,100,000			$ 355,900,000
Number of shares issued (in shares) | shares	6,325,000			5,750,000
Shares issued, price per share (in dollars per share) | $ / shares	$ 62.00			$ 62.50
Underwriting discount and offering costs	$ 5,000,000			$ 3,500,000
Over-Allotment Option | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares issued (in shares) | shares	825,000			750,000